Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Nurix Therapeutics (NRIX) Receivables - Net (2021 - 2025)

Nurix Therapeutics (NRIX) has disclosed Receivables - Net for 4 consecutive years, with $19.0 million as the latest value for Q2 2025.

  • On a quarterly basis, Receivables - Net changed N/A to $19.0 million in Q2 2025 year-over-year; TTM through May 2025 was $19.0 million, a N/A change, with the full-year FY2021 number at $6.0 million, changed N/A from a year prior.
  • Receivables - Net was $19.0 million for Q2 2025 at Nurix Therapeutics, up from $2.0 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $19.0 million in Q2 2025 to a low of $2.0 million in Q3 2023.
  • A 4-year average of $7.1 million and a median of $6.0 million in 2021 define the central range for Receivables - Net.